Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer
- 1 February 2003
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 39 (2) , 145-149
- https://doi.org/10.1016/s0169-5002(02)00441-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Function and Clinical Significance of Platelet-Derived MicroparticlesInternational Journal of Hematology, 2001
- Relation between the Serum E-Selectin Level and the Survival Rate of Patients with Resected Non-small Cell Lung CancersJapanese Journal of Cancer Research, 1999
- Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery diseaseEuropean Journal of Clinical Investigation, 1996
- Platelets and Cancer Metastasis: More Than an EpiphenomenonSeminars in Thrombosis and Hemostasis, 1992
- Cancer Cell Procoagulants and Their Role in Malignant DiseaseSeminars in Thrombosis and Hemostasis, 1992
- Differences between platelet and microparticle glycoprotein IIb/IIIaCytometry, 1992
- Human lung adenocarcinoma cell lines with different lung colonization potential (LCP), and a correlation between expression of sialosyl dimeric Lex (defined by MAb FH6) and LCPClinical & Experimental Metastasis, 1991
- Factor X-activating procoagulant in normal and malignant breast tissueHematological Oncology, 1990
- Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignanciesInternational Journal of Cancer, 1990
- Flow‐cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated plateletsCytometry, 1990